APO RESEARCH · REPORT
Marine Biotechnology
Marine biotechnology is an innovative field of research in science and engineering that encompasses the use of marine bioresources for a multitude of applications, including the production of food, fuel, materials or specific, often bioactive, compounds and may contribute to green growth and sustainable industries and prosperous communities.Marine biotechnological advancements have already resulted in some successes in diverse fields, including human health, pharmacology, fisheries, environmental recovery or restoration, food and cosmetics industries, agriculture and chemistry. Examples of applications resulting from biotechnological developments include the use of (micro- and macro-) algae for the production of biofuels and the production of marine-derived polysaccharides, which are one of the most abundant renewable biomaterials found on land and in the oceans.
Product & engineering
Understand the product.
Marine biotechnology is an innovative field of research in science and engineering that encompasses the use of marine bioresources for a multitude of applications, including the production of food, fuel, materials or specific, often bioactive, compounds and may contribute to green growth and sustainable industries and prosperous communities.Marine biotechnological advancements have already resulted in some successes in diverse fields, including human health, pharmacology, fisheries, environmental recovery or restoration, food and cosmetics industries, agriculture and chemistry. Examples of applications resulting from biotechnological developments include the use of (micro- and macro-) algae for the production of biofuels and the production of marine-derived polysaccharides, which are one of the most abundant renewable biomaterials found on land and in the oceans.
Selected research
Market Outlook & Growth Opportunities
Global Marine Biotechnology Market Outlook and Growth Opportunities 2026
Market perspective
Marine biotechnology is an innovative field of research in science and engineering that encompasses the use of marine bioresources for a multitude of applications, including the production of food, fuel, materials or specific, often bioactive, compounds and may contribute to green growth and sustainable industries and prosperous communities.Marine biotechnological advancements have already resulted in some successes in diverse fields, including human health, pharmacology, fisheries, environmental recovery or restoration, food and cosmetics industries, agriculture and chemistry. Examples of applications resulting from biotechnological developments include the use of (micro- and macro-) algae for the production of biofuels and the production of marine-derived polysaccharides, which are one of the most abundant renewable biomaterials found on land and in the oceans.
The major players in global Marine Biotechnology market include Nofima, Sams, Aquapharm etc., and the market concentration rate is low. North America and Europe are main markets, they occupy over 60% of the global market. Marine Plant Technology is the main type, with a share about 60%. Pharmaceuticals and Nutritional Supplements are two key applications, they hold a share over 60%.
This report provides an overview of the global Marine Biotechnology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Marine Biotechnology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Biotechnology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Marine Biotechnology market.
Marine Biotechnology Segment by Company
Marinova
NEB
BiotechMarine
GlycoMar
Marine Biotech
Nofima
Sams
Aquapharm
Marine Biotechnology Segment by Type
Marine Animal Technolog
Marine Plant Technology
Marine Biotechnology Segment by Application
Cosmetics
Pharmaceuticals
Fine Chemical
Nutritional Supplements
Marine Biotechnology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Marine Biotechnology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Marine Biotechnology key companies, revenue, market share, and recent developments.
3. To split the Marine Biotechnology breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Marine Biotechnology market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Marine Biotechnology significant trends, drivers, influence factors in global and regions.
6. To analyze Marine Biotechnology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Biotechnology industry.
Chapter 3: Detailed analysis of Marine Biotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Marine Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Marine Biotechnology in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Animal Technolog
- Marine Plant Technology
Applications
- Cosmetics
- Pharmaceuticals
- Fine Chemical
- Nutritional Supplements
Companies covered
- Marinova
- NEB
- BiotechMarine
- GlycoMar
- Marine Biotech
- Nofima
- Sams
- Aquapharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Marine Biotechnology Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Marine Biotechnology Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Marine Biotechnology Market Dynamics
- 2.1 Marine Biotechnology Industry Trends
- 2.2 Marine Biotechnology Industry Drivers
- 2.3 Marine Biotechnology Industry Opportunities and Challenges
- 2.4 Marine Biotechnology Industry Restraints
3 Marine Biotechnology Market by Company
- 3.1 Global Marine Biotechnology Company Revenue Ranking in 2025
- 3.2 Global Marine Biotechnology Revenue by Company (2021-2026)
- 3.3 Global Marine Biotechnology Company Ranking (2024-2026)
- 3.4 Global Marine Biotechnology Company Manufacturing Base and Headquarters
- 3.5 Global Marine Biotechnology Company Product Type and Application
- 3.6 Global Marine Biotechnology Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Marine Biotechnology Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Marine Biotechnology Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Marine Biotechnology Market by Type
- 4.1 Marine Biotechnology Type Introduction
- 4.1.1 Marine Animal Technolog
- 4.1.2 Marine Plant Technology
- 4.2 Global Marine Biotechnology Sales Value by Type
- 4.2.1 Global Marine Biotechnology Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Marine Biotechnology Sales Value by Type (2021-2032)
- 4.2.3 Global Marine Biotechnology Sales Value Share by Type (2021-2032)
5 Marine Biotechnology Market by Application
- 5.1 Marine Biotechnology Application Introduction
- 5.1.1 Cosmetics
- 5.1.2 Pharmaceuticals
- 5.1.3 Fine Chemical
- 5.1.4 Nutritional Supplements
- 5.2 Global Marine Biotechnology Sales Value by Application
- 5.2.1 Global Marine Biotechnology Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Marine Biotechnology Sales Value by Application (2021-2032)
- 5.2.3 Global Marine Biotechnology Sales Value Share by Application (2021-2032)
6 Marine Biotechnology Regional Value Analysis
- 6.1 Global Marine Biotechnology Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Marine Biotechnology Sales Value by Region (2021-2032)
- 6.2.1 Global Marine Biotechnology Sales Value by Region: 2021-2026
- 6.2.2 Global Marine Biotechnology Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Marine Biotechnology Sales Value (2021-2032)
- 6.3.2 North America Marine Biotechnology Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Marine Biotechnology Sales Value (2021-2032)
- 6.4.2 Europe Marine Biotechnology Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Marine Biotechnology Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Marine Biotechnology Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Marine Biotechnology Sales Value (2021-2032)
- 6.6.2 South America Marine Biotechnology Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Marine Biotechnology Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Marine Biotechnology Sales Value Share by Country, 2025 VS 2032
7 Marine Biotechnology Country-level Value Analysis
- 7.1 Global Marine Biotechnology Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Marine Biotechnology Sales Value by Country (2021-2032)
- 7.2.1 Global Marine Biotechnology Sales Value by Country (2021-2026)
- 7.2.2 Global Marine Biotechnology Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.7.2 France Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.14.2 China Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.17.2 India Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Marine Biotechnology Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Marine Biotechnology Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Marine Biotechnology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Marinova
- 8.1.1 Marinova Company Information
- 8.1.2 Marinova Business Overview
- 8.1.3 Marinova Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.1.4 Marinova Marine Biotechnology Product Portfolio
- 8.1.5 Marinova Recent Developments
- 8.2 NEB
- 8.2.1 NEB Company Information
- 8.2.2 NEB Business Overview
- 8.2.3 NEB Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.2.4 NEB Marine Biotechnology Product Portfolio
- 8.2.5 NEB Recent Developments
- 8.3 BiotechMarine
- 8.3.1 BiotechMarine Company Information
- 8.3.2 BiotechMarine Business Overview
- 8.3.3 BiotechMarine Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.3.4 BiotechMarine Marine Biotechnology Product Portfolio
- 8.3.5 BiotechMarine Recent Developments
- 8.4 GlycoMar
- 8.4.1 GlycoMar Company Information
- 8.4.2 GlycoMar Business Overview
- 8.4.3 GlycoMar Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.4.4 GlycoMar Marine Biotechnology Product Portfolio
- 8.4.5 GlycoMar Recent Developments
- 8.5 Marine Biotech
- 8.5.1 Marine Biotech Company Information
- 8.5.2 Marine Biotech Business Overview
- 8.5.3 Marine Biotech Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.5.4 Marine Biotech Marine Biotechnology Product Portfolio
- 8.5.5 Marine Biotech Recent Developments
- 8.6 Nofima
- 8.6.1 Nofima Company Information
- 8.6.2 Nofima Business Overview
- 8.6.3 Nofima Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.6.4 Nofima Marine Biotechnology Product Portfolio
- 8.6.5 Nofima Recent Developments
- 8.7 Sams
- 8.7.1 Sams Company Information
- 8.7.2 Sams Business Overview
- 8.7.3 Sams Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.7.4 Sams Marine Biotechnology Product Portfolio
- 8.7.5 Sams Recent Developments
- 8.8 Aquapharm
- 8.8.1 Aquapharm Company Information
- 8.8.2 Aquapharm Business Overview
- 8.8.3 Aquapharm Marine Biotechnology Revenue and Gross Margin (2021-2026)
- 8.8.4 Aquapharm Marine Biotechnology Product Portfolio
- 8.8.5 Aquapharm Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst